Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

DEXCOM INC Director's Dealing 2016

Mar 24, 2016

30198_dirs_2016-03-24_a3d3fe39-1323-4a37-acf4-ac68bd5f318e.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: DEXCOM INC (DXCM)
CIK: 0001093557
Period of Report: 2016-03-22

Reporting Person: GREGG TERRANCE H (Director, Executive Chairman)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2016-03-22 Common Stock S 25000.0 $59.51 Disposed 276064 Indirect

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 477328 Direct
Common Stock 11461 Indirect

Footnotes

F1: The reporting person contributed Dexcom, Inc. Common Stock to an exchange fund, pursuant to an agreement dated November 23, 2015 to contribute shares of DexCom, Inc. Common Stock in exchange for shares of the exchange fund. The Dexcom, Inc. Common Stock was valued at $59.51 per share for the purposes of determining the number of shares of the exchange fund issuable to the reporting person with respect to the March 22, 2016 closing of the exchange fund.

F2: Shares are held by the Gregg Family Trust U/A/D 12/23/1998, with respect to which the reporting person is a trustee.